Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 11, 2021

SELL
$59.31 - $78.82 $235,757 - $313,309
-3,975 Closed
0 $0
Q4 2020

Feb 04, 2021

SELL
$50.47 - $66.26 $1,261 - $1,656
-25 Reduced 0.63%
3,975 $238,000
Q3 2020

Nov 05, 2020

SELL
$51.97 - $63.0 $51,970 - $63,000
-1,000 Reduced 20.0%
4,000 $240,000
Q2 2020

Aug 07, 2020

BUY
$30.8 - $52.47 $154,000 - $262,350
5,000 New
5,000 $262,000
Q1 2018

May 02, 2018

SELL
$29.98 - $46.35 $4.59 Million - $7.1 Million
-153,185 Closed
0 $0
Q4 2017

Feb 07, 2018

SELL
$31.85 - $46.95 $88,797 - $130,896
-2,788 Reduced 1.79%
153,185 $6.99 Million
Q3 2017

Nov 08, 2017

BUY
$35.7 - $39.5 $5.57 Million - $6.16 Million
155,973
155,973 $5.86 Million

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $870M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Biondo Investment Advisors, LLC Portfolio

Follow Biondo Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Biondo Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Biondo Investment Advisors, LLC with notifications on news.